Randomized, open-label, multicenter, phase III study of eribulin versus dacarbazine in patients (pts) with leiomyosarcoma (LMS) and adipocytic sarcoma (ADI)
Schoeffski, Patrick ; Maki, Robert G ; Italiano, Antoine ; Gelderblom, Hans ; Grignani, Giovanni ; De Camargo, Veridiana Pires ; Bauer, Sebastian ; Rha, Sun Young ; Chawla, Sant P ; Blay, Jean-Yves ; Hohenberger, Peter ; D'Adamo, David R ; Wang, Benjamin ; Chmielowski, Bartosz ; Le Cesne, Axel ; Demetri, George D ; Patel, Shreyaskumar
JOURNAL OF CLINICAL ONCOLOGY, 2015, Vol.33 (15)AMER SOC CLINICAL ONCOLOGY
Texto completo disponible